Our technology has also been shown to improve circulation in diabetics, promote wound healing and help push back muscle atrophy.
We pride ourselves on creating effective technology that helps everyone reach their goals and we know the only way to do that is to start from a proven foundation.
Using clinical trials, collaborations with leading academic institutions, and user feedback, we ensure that our technology is not only founded on best practice, but that we have the evidence needed to elevate bioelectronics to become a mainstream pillar of modern medicine.
But we don’t expect people to just take our word for it, and that’s why we encourage third-party testing of our technology.
Machine learning and AI is already changing every area of society, including health, but we’re pushing it further to integrate it with our app-controlled treatment systems.
Users will have the option to draw on sophisticated personalisation capabilities that draw on an extensive knowledge base, while understanding user intent to provide dynamic and optimised treatment programmes for every individual.
Bioelectronic technology is already drawing interest from players across the pharmaceutical and healthcare industries, but they lag behind us, in innovation, speed of development and impact created.
We’ve unlocked the true potential of microcurrent technology for health and wellbeing by combining multiple microcurrent waveforms to stimulate the body’s systems in the right order to achieve the best possible results.
Our market disruption is only the beginning as we move to become the leader in the next healthcare revolution. Healing amplification, pain management, performance optimisation – all can be achieved with our signature NuroKor technology.